Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 22 | 2022 | 1800 | 2.130 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2021 | 1321 | 1.970 |
Why?
|
| Cognitive Dysfunction | 13 | 2022 | 1095 | 1.600 |
Why?
|
| Gait | 6 | 2021 | 407 | 1.360 |
Why?
|
| Hippocampus | 6 | 2020 | 284 | 1.270 |
Why?
|
| Exercise | 6 | 2021 | 505 | 1.060 |
Why?
|
| Cognition | 10 | 2022 | 1429 | 1.020 |
Why?
|
| Aged, 80 and over | 30 | 2022 | 5196 | 0.950 |
Why?
|
| Alzheimer Disease | 15 | 2022 | 2138 | 0.950 |
Why?
|
| Postural Balance | 3 | 2021 | 124 | 0.900 |
Why?
|
| Aging | 8 | 2021 | 1729 | 0.880 |
Why?
|
| Postmortem Changes | 2 | 2016 | 34 | 0.870 |
Why?
|
| Neuropathology | 3 | 2021 | 87 | 0.850 |
Why?
|
| Independent Living | 5 | 2021 | 321 | 0.840 |
Why?
|
| Wearable Electronic Devices | 5 | 2021 | 43 | 0.730 |
Why?
|
| White Matter | 5 | 2018 | 157 | 0.690 |
Why?
|
| Male | 37 | 2022 | 16488 | 0.680 |
Why?
|
| Female | 37 | 2022 | 17004 | 0.670 |
Why?
|
| Autopsy | 9 | 2021 | 352 | 0.610 |
Why?
|
| Humans | 49 | 2022 | 31058 | 0.610 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2021 | 86 | 0.600 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2018 | 55 | 0.590 |
Why?
|
| Aged | 27 | 2022 | 10077 | 0.590 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2018 | 120 | 0.560 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 737 | 0.520 |
Why?
|
| Motor Activity | 1 | 2018 | 370 | 0.490 |
Why?
|
| Atrophy | 3 | 2021 | 103 | 0.480 |
Why?
|
| Thalamus | 3 | 2021 | 24 | 0.470 |
Why?
|
| Knee Joint | 1 | 2019 | 827 | 0.420 |
Why?
|
| Parkinsonian Disorders | 3 | 2020 | 234 | 0.410 |
Why?
|
| Accelerometry | 4 | 2021 | 94 | 0.390 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2019 | 81 | 0.390 |
Why?
|
| Walking | 4 | 2022 | 258 | 0.380 |
Why?
|
| Neuroimaging | 3 | 2021 | 144 | 0.370 |
Why?
|
| Walking Speed | 2 | 2021 | 43 | 0.350 |
Why?
|
| Gray Matter | 3 | 2021 | 59 | 0.340 |
Why?
|
| Geriatric Assessment | 3 | 2021 | 238 | 0.340 |
Why?
|
| Formaldehyde | 1 | 2009 | 16 | 0.330 |
Why?
|
| Longitudinal Studies | 7 | 2021 | 1506 | 0.330 |
Why?
|
| RNA, Messenger | 2 | 2022 | 329 | 0.320 |
Why?
|
| Cohort Studies | 9 | 2020 | 2041 | 0.300 |
Why?
|
| Temporal Lobe | 2 | 2020 | 104 | 0.300 |
Why?
|
| Brain Mapping | 3 | 2017 | 193 | 0.290 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 230 | 0.290 |
Why?
|
| Dementia | 2 | 2022 | 561 | 0.260 |
Why?
|
| Parkinson Disease | 4 | 2021 | 1066 | 0.250 |
Why?
|
| Organ Size | 3 | 2015 | 108 | 0.250 |
Why?
|
| Nerve Net | 2 | 2021 | 52 | 0.220 |
Why?
|
| Sclerosis | 3 | 2019 | 71 | 0.220 |
Why?
|
| DNA Methylation | 3 | 2019 | 132 | 0.210 |
Why?
|
| Transcriptome | 2 | 2022 | 89 | 0.210 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 105 | 0.210 |
Why?
|
| Neuropsychological Tests | 3 | 2022 | 1317 | 0.200 |
Why?
|
| Proteome | 1 | 2022 | 44 | 0.200 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2021 | 8 | 0.190 |
Why?
|
| Tremor | 2 | 2021 | 141 | 0.190 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2021 | 12 | 0.190 |
Why?
|
| Proteomics | 1 | 2022 | 97 | 0.190 |
Why?
|
| Motor Skills | 1 | 2021 | 61 | 0.190 |
Why?
|
| Cerebrovascular Disorders | 1 | 2022 | 149 | 0.190 |
Why?
|
| Neuropeptides | 2 | 2019 | 31 | 0.180 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2019 | 113 | 0.180 |
Why?
|
| Hand Strength | 1 | 2021 | 62 | 0.180 |
Why?
|
| Frailty | 1 | 2021 | 39 | 0.180 |
Why?
|
| Sarcopenia | 1 | 2021 | 33 | 0.180 |
Why?
|
| Gene Expression | 2 | 2019 | 239 | 0.180 |
Why?
|
| Cognitive Aging | 1 | 2021 | 87 | 0.180 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 119 | 0.170 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 7 | 0.170 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 19 | 0.170 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 14 | 0.170 |
Why?
|
| Brain Ischemia | 1 | 2020 | 75 | 0.170 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 14 | 0.170 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 27 | 0.160 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 91 | 0.160 |
Why?
|
| Cognition Disorders | 3 | 2017 | 1057 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 197 | 0.160 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2021 | 144 | 0.160 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 140 | 0.160 |
Why?
|
| Disabled Persons | 1 | 2021 | 135 | 0.160 |
Why?
|
| Memory | 3 | 2017 | 330 | 0.160 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2018 | 19 | 0.160 |
Why?
|
| Electric Stimulation Therapy | 1 | 2018 | 46 | 0.160 |
Why?
|
| Bone Resorption | 1 | 2019 | 97 | 0.160 |
Why?
|
| Muscle Strength | 1 | 2019 | 136 | 0.150 |
Why?
|
| Nerve Fibers | 1 | 2018 | 14 | 0.150 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 23 | 0.140 |
Why?
|
| Circle of Willis | 1 | 2017 | 6 | 0.140 |
Why?
|
| Young Adult | 6 | 2021 | 2057 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 48 | 0.140 |
Why?
|
| Brain Infarction | 1 | 2017 | 74 | 0.140 |
Why?
|
| Ultraviolet Therapy | 1 | 2017 | 1 | 0.140 |
Why?
|
| Disability Evaluation | 1 | 2019 | 333 | 0.140 |
Why?
|
| Linear Models | 2 | 2016 | 272 | 0.140 |
Why?
|
| Epithalamus | 1 | 2016 | 3 | 0.140 |
Why?
|
| Afferent Pathways | 1 | 2016 | 5 | 0.140 |
Why?
|
| Sphenoid Sinus | 1 | 2016 | 15 | 0.140 |
Why?
|
| Plasmacytoma | 1 | 2016 | 19 | 0.140 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 50 | 0.140 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 85 | 0.140 |
Why?
|
| Skin Diseases | 1 | 2017 | 28 | 0.140 |
Why?
|
| Femur | 1 | 2020 | 402 | 0.140 |
Why?
|
| Adult | 10 | 2021 | 8945 | 0.130 |
Why?
|
| Neurons | 1 | 2019 | 377 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 176 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2017 | 185 | 0.130 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2016 | 62 | 0.130 |
Why?
|
| Neocortex | 1 | 2016 | 34 | 0.130 |
Why?
|
| Femoracetabular Impingement | 1 | 2020 | 218 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 367 | 0.120 |
Why?
|
| Algorithms | 2 | 2019 | 416 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 65 | 0.120 |
Why?
|
| Joint Instability | 1 | 2019 | 405 | 0.120 |
Why?
|
| Middle Aged | 8 | 2021 | 10235 | 0.120 |
Why?
|
| Locomotion | 1 | 2014 | 25 | 0.110 |
Why?
|
| Shoulder Joint | 1 | 2019 | 606 | 0.110 |
Why?
|
| Models, Anatomic | 1 | 2010 | 54 | 0.090 |
Why?
|
| Memory, Episodic | 1 | 2011 | 128 | 0.090 |
Why?
|
| Mortality | 2 | 2021 | 89 | 0.090 |
Why?
|
| Fixatives | 1 | 2009 | 7 | 0.080 |
Why?
|
| Sex Factors | 2 | 2021 | 508 | 0.080 |
Why?
|
| Risk Factors | 3 | 2021 | 2587 | 0.080 |
Why?
|
| Chicago | 2 | 2021 | 939 | 0.070 |
Why?
|
| Lewy Bodies | 2 | 2019 | 206 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 274 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 226 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 818 | 0.060 |
Why?
|
| Photosensitivity Disorders | 1 | 2003 | 1 | 0.060 |
Why?
|
| Sunlight | 1 | 2003 | 3 | 0.060 |
Why?
|
| Urticaria | 1 | 2003 | 3 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 820 | 0.060 |
Why?
|
| Adolescent | 3 | 2017 | 2400 | 0.050 |
Why?
|
| Depression | 2 | 2017 | 481 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 27 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 43 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2022 | 78 | 0.050 |
Why?
|
| Executive Function | 1 | 2022 | 125 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2021 | 32 | 0.050 |
Why?
|
| Frail Elderly | 1 | 2021 | 52 | 0.050 |
Why?
|
| Prognosis | 2 | 2019 | 924 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 231 | 0.040 |
Why?
|
| Nestin | 1 | 2019 | 3 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2019 | 4 | 0.040 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2019 | 9 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2019 | 15 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2019 | 12 | 0.040 |
Why?
|
| Movement | 1 | 2020 | 137 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 21 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 1936 | 0.040 |
Why?
|
| SNARE Proteins | 1 | 2019 | 14 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2020 | 102 | 0.040 |
Why?
|
| Epilepsies, Partial | 1 | 2018 | 24 | 0.040 |
Why?
|
| Software | 1 | 2019 | 73 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2019 | 3664 | 0.040 |
Why?
|
| Life Style | 1 | 2020 | 226 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 62 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 11 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 13 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 44 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 44 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 145 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2019 | 686 | 0.040 |
Why?
|
| Shoulder Injuries | 1 | 2019 | 143 | 0.040 |
Why?
|
| Netrin Receptors | 1 | 2017 | 5 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2018 | 301 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 46 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 872 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1006 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 783 | 0.040 |
Why?
|
| RNA | 1 | 2017 | 39 | 0.040 |
Why?
|
| Child | 2 | 2017 | 1428 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2017 | 15 | 0.040 |
Why?
|
| Habenula | 1 | 2016 | 3 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 832 | 0.040 |
Why?
|
| Phototherapy | 1 | 2017 | 38 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 76 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2017 | 89 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 236 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 551 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1134 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 145 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 318 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 320 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 428 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 76 | 0.030 |
Why?
|
| Actigraphy | 1 | 2016 | 99 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1897 | 0.030 |
Why?
|
| United States | 1 | 2021 | 2376 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 151 | 0.030 |
Why?
|
| Hypokinesia | 1 | 2014 | 28 | 0.030 |
Why?
|
| Muscle Rigidity | 1 | 2014 | 26 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2013 | 60 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 215 | 0.030 |
Why?
|
| Sleep | 1 | 2016 | 322 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 315 | 0.020 |
Why?
|
| Cadaver | 1 | 2013 | 380 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 586 | 0.020 |
Why?
|
| Radiography | 1 | 2009 | 695 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2003 | 689 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 1679 | 0.010 |
Why?
|